Association of ticagrelor vs clopidogrel with net adverse clinical events in NSTEMI patients with mild thrombocytopenia

Back

ESC Professional Premium Access

Association of ticagrelor vs clopidogrel with net adverse clinical events in NSTEMI patients with mild thrombocytopenia

Session: Cardiovascular risk and interventions: comparisons, disparities, and clinical trials

Topic: Big Data Analysis

Speaker: Professor K. Chen (Tianjin, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

0 follower

5 more presentations in this session

GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure

Speaker: Doctor L. Roberts (Reading, GB)

Education level and the incidence of heart failure, acute myocardial infarction, and stroke in patients with atrial fibrillation

Speaker: Doctor A. Sztaniszlav (Orebro, SE)

Factors associated with major adverse cardiovascular events among Arabs and Jews in Israel: a population-based cohort study

Speaker: Associate Professor O. Kalter-Leibovici (Ramat Gan, IL)

Assessing aortic morphology post aortic valve replacement using unsupervised hierarchical clustering and statistical shape modelling

Speaker: Mr Y. Aljassam (Bristol, GB)

Sub-Saharan Africa's contribution to clinical trials in international acute coronary syndromes and heart failure guidelines

Speaker: Doctor J. Hudson (London, GB)

Access the full session

Cardiovascular risk and interventions: comparisons, disparities, and clinical trials

Speakers: Professor K. Chen, Doctor L. Roberts, Doctor A. Sztaniszlav, Associate Professor O. Kalter-Leibovici, Mr Y. Aljassam...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources